emerging glp-1 gip obesity treatments 2025 Harnessing Receptor Agonists for Treatment: Prospects and Obstacles on the Horizon From evidence to action: WHO

The gut, it seemed, held a secret

A patient carrying certain GLP1R or GIPR variants may show stronger appetite suppression or metabolic adaptation, but individual outcomes depend on adherence, diet, exercise, and overall health status

With both recruitment and retention on the decline, maintaining fit and capable personnel is critical to ensure a force structure sufficient to combat rising global threats," the researchers wrote

While massive, double-blind, randomized controlled trials (RCTs) investigating ALCAR as a standalone intervention for Long COVID are still pending, these early case-control studies strongly validate its use as a supportive, rehabilitative therapy for patients struggling with post-viral metabolic exhaustion

Breastfeeding: Its not known whether its safe to take Januvia while breastfeeding

Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization